Improving Drug Development Speed with AI in L...

Enterprise sales teams routinely let the majority of inbound leads go untouched simply because there isn't enough team bandwidth to work them all. In this episode, Vanessa Tabbert, VP of Agentic Transformation and Sales Development at Salesforce, breaks down how her own team depl ...  Show more

Large B2B operations keep running order entry, invoicing, and other repetitive back-office workflows by hand, years after most companies started investing heavily in AI. In this episode, Chris Bradley, Chief Marketing Officer and Head of AI Transformation at Veritiv, breaks down ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more

Our guest today is Eric Boyd, the Corporate Vice President of AI at Microsoft. Eric joins us to share how organizations can leverage AI for faster development. Eric shared the benefits of using natural language to build products. He discussed the future of version control and the ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more